Relationship of early rapid weight loss to efficacy and safety of tirzepatide and semaglutide for obesity: SURMOUNT-5 post hoc analysis.

Saved in:
Bibliographic Details
Title: Relationship of early rapid weight loss to efficacy and safety of tirzepatide and semaglutide for obesity: SURMOUNT-5 post hoc analysis.
Authors: Aronne LJ; Division of Endocrinology, Diabetes and Metabolism, Comprehensive Weight Control Center, Weill Cornell Medicine, New York, NY, USA. Electronic address: ljaronne@med.cornell.edu., Horn DB; Center for Obesity Medicine and Metabolic Performance, Department of Surgery, University of Texas McGovern Medical School, Houston, TX, USA., Kokkinos AD; First Department of Propaedeutic Internal Medicine, Medical School, National and Kapodistrian University of Athens, Laiko General Hospital, Athens, Greece., Falcon BL; Eli Lilly and Company, Indianapolis, IN, USA., Wang H; TechData Service, King of Prussia, PA, USA., Hoffmann HT; Eli Lilly and Company, Indianapolis, IN, USA., Lee CJ; Eli Lilly and Company, Indianapolis, IN, USA., Dunn JP; Eli Lilly and Company, Indianapolis, IN, USA.
Source: The American journal of medicine [Am J Med] 2026 Jul; Vol. 139 (7), pp. 913-921. Date of Electronic Publication: 2026 Mar 20.
Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial
Journal Info: Publisher: Excerpta Medica Country of Publication: United States NLM ID: 0267200 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1555-7162 (Electronic) Linking ISSN: 00029343 NLM ISO Abbreviation: Am J Med Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41865857
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Relationship of early rapid weight loss to efficacy and safety of tirzepatide and semaglutide for obesity: SURMOUNT-5 post hoc analysis.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Aronne+LJ%22">Aronne LJ</searchLink>; Division of Endocrinology, Diabetes and Metabolism, Comprehensive Weight Control Center, Weill Cornell Medicine, New York, NY, USA. Electronic address: ljaronne@med.cornell.edu.<br /><searchLink fieldCode="AU" term="%22Horn+DB%22">Horn DB</searchLink>; Center for Obesity Medicine and Metabolic Performance, Department of Surgery, University of Texas McGovern Medical School, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Kokkinos+AD%22">Kokkinos AD</searchLink>; First Department of Propaedeutic Internal Medicine, Medical School, National and Kapodistrian University of Athens, Laiko General Hospital, Athens, Greece.<br /><searchLink fieldCode="AU" term="%22Falcon+BL%22">Falcon BL</searchLink>; Eli Lilly and Company, Indianapolis, IN, USA.<br /><searchLink fieldCode="AU" term="%22Wang+H%22">Wang H</searchLink>; TechData Service, King of Prussia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Hoffmann+HT%22">Hoffmann HT</searchLink>; Eli Lilly and Company, Indianapolis, IN, USA.<br /><searchLink fieldCode="AU" term="%22Lee+CJ%22">Lee CJ</searchLink>; Eli Lilly and Company, Indianapolis, IN, USA.<br /><searchLink fieldCode="AU" term="%22Dunn+JP%22">Dunn JP</searchLink>; Eli Lilly and Company, Indianapolis, IN, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220267200%22">The American journal of medicine</searchLink> [Am J Med] 2026 Jul; Vol. 139 (7), pp. 913-921. <i>Date of Electronic Publication: </i>2026 Mar 20.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Excerpta+Medica%22">Excerpta Medica </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0267200 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1555-7162 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200029343%22">00029343 </searchLink><i>NLM ISO Abbreviation: </i>Am J Med <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41865857
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.amjmed.2026.03.010
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 913
    Titles:
      – TitleFull: Relationship of early rapid weight loss to efficacy and safety of tirzepatide and semaglutide for obesity: SURMOUNT-5 post hoc analysis.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Aronne LJ
      – PersonEntity:
          Name:
            NameFull: Horn DB
      – PersonEntity:
          Name:
            NameFull: Kokkinos AD
      – PersonEntity:
          Name:
            NameFull: Falcon BL
      – PersonEntity:
          Name:
            NameFull: Wang H
      – PersonEntity:
          Name:
            NameFull: Hoffmann HT
      – PersonEntity:
          Name:
            NameFull: Lee CJ
      – PersonEntity:
          Name:
            NameFull: Dunn JP
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 07
              Text: 2026 Jul
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1555-7162
          Numbering:
            – Type: volume
              Value: 139
            – Type: issue
              Value: 7
          Titles:
            – TitleFull: The American journal of medicine
              Type: main
ResultId 1